Compound · Metabolic Research

Retatrutide

Retatrutide is a synthetic peptide agonist of three incretin receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and the glucagon receptor. It is the subject of ongoing third-party Phase 3 metabolic research programs. Supplied as...

£79 1 vial - 10 mg

In Stock · Ships 24h

Vial Size

Research Use Only This product is supplied for laboratory research and development purposes exclusively. Not for human or veterinary consumption. By purchasing you confirm you are a qualified researcher.

Description

Retatrutide is a synthetic peptide agonist of three incretin receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and the glucagon receptor.

It is the subject of ongoing third-party Phase 3 metabolic research programs. Supplied as a sterile lyophilised powder for laboratory analysis only.

CAS Number: 2381089-83-2
Sequence: Modified 39-aa peptide
Purity: ≥ 98.5% (HPLC verified)
Molecular Weight: 4731.4 g/mol
Form: Lyophilised peptide

Research use only. Not for human or veterinary consumption.

Specification

Appearance: White lyophilised powder
Storage: –20 °C, desiccated
Form: Lyophilised peptide
Solubility: Bacteriostatic water

Handling & Storage

On arrival, vials should be stored at −20 °C in their original sealed condition. Reconstitution should be performed in sterile bacteriostatic water under appropriate laboratory conditions.

All handling must be carried out by qualified personnel using appropriate PPE in compliance with institutional and local biosafety regulations.